Yejun Yan

Effects of dapagliflozin on inflammatory biomarkers and cardiac function in patients with acute myocardial infarction after percutaneous coronary intervention and type 2 diabetes: an exploratory observational study with propensity score matching

Abstract Background Acute myocardial infarction (AMI) triggers a robust inflammatory response that contributes to adverse ventricular remodeling. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated anti-inflammatory properties beyond glycemic control, but their ef...